Assembly Biosciences, Inc.
ASMB
$32.87
-$2.41-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -42.00K | -6.38M | -6.12M | -38.55M | -38.96M |
| Total Depreciation and Amortization | 110.00K | 122.00K | 129.00K | 129.00K | 130.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.46M | 3.29M | 3.18M | 2.86M | 1.92M |
| Change in Net Operating Assets | -43.01M | -36.78M | -38.28M | -20.18M | -18.93M |
| Cash from Operations | -38.48M | -39.75M | -41.09M | -55.74M | -55.85M |
| Capital Expenditure | -85.00K | -85.00K | -66.00K | -42.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -234.43M | -125.35M | -113.40M | -141.35M | 41.37M |
| Cash from Investing | -234.51M | -125.44M | -113.47M | -141.39M | 41.37M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 281.27M | 172.89M | 174.67M | 191.21M | 19.27M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 281.27M | 172.89M | 174.67M | 191.21M | 19.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.28M | 7.71M | 20.11M | -5.92M | 4.80M |